ArticleViruses2016

Divergent Trends of Anti-JCPyV Serum Reactivity and Neutralizing Activity in Multiple Sclerosis (MS) Patients during Treatment with Natalizumab.

Roberta Antonia Diotti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.